Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease
- PMID: 1869735
- DOI: 10.1016/0735-1097(91)90795-b
Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease
Abstract
To assess the use of adenosine as an alternative agent for determination of coronary vasodilator reserve, hemodynamics and coronary blood flow velocity were measured at rest and during peak hyperemic responses to continuous intravenous adenosine infusion (50, 100 and 150 micrograms/kg per min for 3 min) and intracoronary papaverine (10 mg) in 34 patients (17 without [group 1] and 17 with [group 2] significant left coronary artery disease), and in 17 patients (11 without and 6 with left coronary artery disease) after low dose (2.5 mg) intravenous bolus injection of adenosine. The maximal adenosine dose did not change mean arterial pressure (-10 +/- 14% and -6 +/- 12% for groups 1 and 2, respectively) but increased the heart rate (15 +/- 18% and 13 +/- 16, respectively). For continuous adenosine infusions, mean coronary flow velocity increased 64 +/- 104%, 122 +/- 94% and 198 +/- 59% and 15 +/- 51%, 110 +/- 95% and 109 +/- 86% in groups 1 and 2, respectively for each of the three doses. Mean coronary flow velocity increased significantly after 100 and 150 micrograms/kg of adenosine and 10 mg of intracoronary papaverine (48 +/- 25, 52 +/- 19 and 54 +/- 21 cm/s, respectively; all p less than 0.05 vs. baseline) and was significantly higher than in group 2 (37 +/- 24, 32 +/- 16, 41 +/- 23 cm/s; all p less than 0.05 vs. group 1). The coronary vasodilator reserve ratio (calculated as the ratio of hyperemic to basal mean flow velocity) for adenosine and papaverine was 2.94 +/- 1.50 and 2.94 +/- 1.00, respectively, in group 1 and was significantly and similarly reduced in group 2 (2.16 +/- 0.81 and 2.38 +/- 0.78, respectively; both p less than 0.05 vs. group 1). Low dose bolus injection of adenosine increased mean velocity equivalently to that after continuous infusion of 100 micrograms/kg, but less than after papaverine. There was a strong correlation between adenosine infusion and papaverine for both mean coronary flow velocity and coronary vasodilator reserve ratio (r2 = 0.871 and 0.325; SEE = 0.068 and 0.189, respectively; both p less than 0.0005). No patient had significant arrhythmias or prolongation of the corrected QT (QTc) interval with adenosine, but papaverine increased the QT (QTc) interval from 445 +/- 44 to 501 +/- 43 ms (p less than 0.001 vs. both maximal adenosine and baseline) and produced nonsustained ventricular tachycardia in one patient.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Effects of adenosine on human coronary arterial circulation.Circulation. 1990 Nov;82(5):1595-606. doi: 10.1161/01.cir.82.5.1595. Circulation. 1990. PMID: 2225364 Clinical Trial.
-
Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.Cathet Cardiovasc Diagn. 1996 Oct;39(2):120-5. doi: 10.1002/(SICI)1097-0304(199610)39:2<120::AID-CCD3>3.0.CO;2-H. Cathet Cardiovasc Diagn. 1996. PMID: 8922309
-
Assessment of coronary reserve by transoesophageal Doppler echocardiography. Direct comparison between different modalities of dipyridamole and adenosine administration.Eur Heart J. 1997 Mar;18(3):514-23. doi: 10.1093/oxfordjournals.eurheartj.a015274. Eur Heart J. 1997. PMID: 9076391
-
[Intravenous adenosine infusion in the assessment of coronary flow reserve in hypertension. Transesophageal Doppler echocardiographic study].Orv Hetil. 1999 Mar 7;140(10):523-7. Orv Hetil. 1999. PMID: 10323067 Review. Hungarian.
-
Coronary vein flow velocity changes during transluminal balloon angioplasty: a study using the Doppler guide wire.Cathet Cardiovasc Diagn. 1997 Jan;40(1):85-91. doi: 10.1002/(sici)1097-0304(199701)40:1<85::aid-ccd17>3.0.co;2-t. Cathet Cardiovasc Diagn. 1997. PMID: 8993823 Review.
Cited by
-
Diagnostic utility and safety of intracoronary nicorandil as a hyperemic agent for the measurement of fractional flow reserve.Indian Heart J. 2020 Nov-Dec;72(6):603-605. doi: 10.1016/j.ihj.2020.10.004. Epub 2020 Oct 20. Indian Heart J. 2020. PMID: 33357653 Free PMC article.
-
Safety and efficacy of intracoronary sodium nitroprusside for the assessment of coronary fractional flow reserve.Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S245-S249. doi: 10.1016/j.ihj.2017.12.008. Epub 2018 Jan 5. Indian Heart J. 2018. PMID: 30595267 Free PMC article.
-
Using multidetector computed tomography in a swine model to assess the effects of sublingual nitroglycerin and intravenous adenosine on epicardial coronary arteries.Comp Med. 2009 Dec;59(6):573-9. Comp Med. 2009. PMID: 20034433 Free PMC article.
-
Coronary flow reserve in the contralateral artery increases after successful coronary angioplasty in patients with spontaneously visible collateral vessels.Heart. 1998 Nov;80(5):493-8. doi: 10.1136/hrt.80.5.493. Heart. 1998. PMID: 9930051 Free PMC article.
-
Coronary flow velocity reserve in hypertensive patients with left ventricular systolic dysfunction.Clin Cardiol. 2002 Mar;25(3):95-102. doi: 10.1002/clc.4960250304. Clin Cardiol. 2002. PMID: 11890376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources